This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

DMPA-SC Access Collaborative Brief

Subcutaneous DMPA (DMPA-SC, brand name Sayana Press) is an innovative injectable contraceptive that can dramatically expand access and choice for women. A new initiative led by PATH and John Snow Inc., the Subcutaneous DMPA Access Collaborative is working with ministries of health and partners across sectors to strengthen scale-up and build toward a robust global market for the product. For more information, visit the DMPA-SC Access Collaborative page or email FPoptions@path.org.

Publication date: January 2018

Available materials

  1. English

    1. Subcutaneous DMPA Access Collaborative brief 217.7 KB PDF

      Hard copies are not available.

  2. French

    1. Subcutaneous DMPA Access Collaborative Brief [French] 201.9 KB PDF

      Hard copies are not available.